Bird & Bird advised Fonds Patient Autonome and Uniqa Ventures on their €4 million financing round of Fizimed

International law firm Bird & Bird advised Fonds Patient Autonome, managed by Bpifrance, and Uniqa Ventures on their participation in the €4 million financing round of Fizimed, a femtech dedicated to women's health.

The Fonds Patient Autonome and Uniqa Ventures led the financing round, in which UI Investissement also participated.

The Bird & Bird team advising Fonds Patient Autonome and Uniqa Ventures comprised of partner Carole Bodin and associate Pascaline Sagot, who advised on the corporate aspects, with partner Alexandre Vuchot and associate Caroline Arrighi-Savoie advising on the regulatory aspects.

The company was advised by Charles Russell Speechlys. The team comprised of partner Renaud Ferry and Counsel Orlando Vignoli Neto.

News & Deals

More News & Deals
Deal Bird & Bird advises Akiem on the acquisition, financing and leasing of a fleet of 14 battery-powered electric trains

Jul 22 2025

Read More
Deal Bird & Bird advises Deutsche Pfandbriefbank AG on the development financing of a warehouse for Hillwood

Jul 22 2025

Read More
Deal Bird & Bird and Sheppard Mullin advise Swansea City AFC on Snoop Dogg co-ownership deal

Jul 21 2025

Read More
Deal Bird & Bird advises BrainEver on its €33 million Series B funding round

Jul 15 2025

Read More
Deal Bird & Bird advises Delixy Holdings Limited as Singapore Counsel on Nasdaq Listing

Jul 15 2025

Read More
Deal Bird & Bird advises Brose Sitech on the acquisition of Proseat including its subsidiaries from Sekisui Kasei

Jul 07 2025

Read More